Dipenine

Dipenine

SCHEMBL29385249

CC[N+](CC)(CC)CCOC(=O)C(C1CCCC1)C1CCCC1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 4/20 0.44
CHRM2 P08172 3/20 0.44
CHRM3 P20309 2/20 0.44
EPHX1 P07099 3/20 0.36
CYP3A4 P08684 2/20 0.35
SLC6A3 Q01959 2/20 0.35
KCNH2 Q12809 2/20 0.35
TSHR P16473 2/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
DRD1 P21728 1/20 0.35
SLC6A2 P23975 1/20 0.35
ADRA1A P35348 1/20 0.35
OPRM1 P35372 1/20 0.35
DRD3 P35462 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
THRB P10828 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dipenine SCHEMBL25069 0.98 CHRM1 (0.43) CHRM1CHRM2CHRM3EPHX1CYP3A4
Penoctonium SCHEMBL29388602 0.87 TSHR (0.40) EPHX1TSHR
Penoctonium SCHEMBL2734618 0.86 DNM1 (0.41) EPHX1CYP3A4TSHRALDH1A1
SCHEMBL28324316 0.76 TSHR (0.47) CHRM1CHRM2EPHX1CYP3A4SLC6A3
SCHEMBL16352924 0.76 ALDH1A1 (0.44) CHRM1CHRM2CHRM3ALDH1A1
SCHEMBL16352894 0.75 ALDH1A1 (0.46) CHRM1CHRM2CHRM3SLC6A3KCNH2
SCHEMBL7537185 0.74 EPHX1 (0.44) CHRM1CHRM2EPHX1CYP3A4SLC6A3
SCHEMBL16352904 0.72 CHRM1 (0.53) CHRM1CHRM2CHRM3TSHRHTR1A
SCHEMBL26311451 0.71 EPHX1 (0.41) EPHX1TSHRTHRBATML3MBTL1
SCHEMBL17189686 0.71 CHRM2 (0.39) CHRM1CHRM2CHRM3CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220047505-A1 Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration STI PHARMA, LLC (US) 2022-02-17 US disclosed